产品研发
RESEARCH

Novel Affinity Ligands- nanoselect


Nanobody and Affibody are new novel affinity ligands, NBbiolab development a series of  unique affinity purification solution based on Camelid&shark-derived single domain antibody fragments(~15KD) and Affibody(6.5KD). These small affinity ligands, are the platform solution for any biopharmaceutical purification challenge and have been proven for many applications to result in a higher yield and an increased purity of the biopharmaceutical, as well as a reduction in the number of purification steps which all affect the cost of goods of the biopharmaceutical. In addition, nanoselect  ligands can be tailored to protect the biopharmaceutical by mild elution conditions. The manufacturing in yeast and Ecoli, without animal derived components, results in a high quality product without toxins and viruses.



Copyright ©2017 成都阿帕克生物科技有限公司 蜀ICP备17007098号-1    
地址:成都市温江区青啤大道319号10幢2单元5楼 电话:400-166-9953 13551086942 邮箱:service@nb-biolab.com
24小时服务热线
400-166-9953
幸运飞艇怎么样稳赚 赌北京pk10怎样才会赢 幸运飞艇真好玩 玩北京pk10有什么技巧 北京pk10怎样才能注册 怎么玩幸运飞艇 幸运飞艇真好玩 玩北京pk10有什么技巧 北京pk10能赢钱吗 北京pk10可以玩嘛